USM institute wins $6 million grant to develop hepatitis C vaccine
The National Institutes of Health has awarded a University System of Maryland institute a $6 million grant to develop a vaccine for the hepatitis C virus.
The Institute for Bioscience and Biotechnology Research will conduct the grant-funded research over a five-year period. The institute is a joint research enterprise between the University of Maryland, College Park, the University of Maryland, Baltimore and the National Institute of Standards and T echnology. The project was initially seeded with…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Morgan Eichensehr Source Type: news
More News: Biotechnology | Grants | Health Management | Hepatitis | Hepatitis C | Hepatitis Vaccine | National Institutes of Health (NIH) | University of Maryland | Vaccines